Advertisement

Topics

Clinical trial fails to disclose risk of death, repeat heart attacks, advocacy group says

06:20 EDT 2 Aug 2017 | Medical Xpress

A clinical trial testing blood transfusion therapies for heart attack patients may place participants in danger of death or a repeat heart attack without fully disclosing those risks, a Washington, D.C.-based consumer advocacy group said Tuesday in a letter asking federal health officials to immediately suspend enrollment in the study, which is recruiting patients at dozens of hospitals, including Mount Sinai Medical Center in Miami Beach.

Original Article: Clinical trial fails to disclose risk of death, repeat heart attacks, advocacy group says

NEXT ARTICLE

More From BioPortfolio on "Clinical trial fails to disclose risk of death, repeat heart attacks, advocacy group says"

Quick Search
Advertisement
 

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...